Literature DB >> 25315585

Preferences for patient medication information: what do patients want?

Julia Kish-Doto1, Monica Scales, Paula Eguino-Medina, Tania Fitzgerald, Janice P Tzeng, Lauren A McCormack, Amie O'Donoghue, Oluwamurewa Oguntimein, Suzanne L West.   

Abstract

This study investigated respondent preferences on how best to display patient medication information (PMI) that accompanies prescription medications to promote comprehension and appropriate usage. The authors identified 30 individuals diagnosed with select immune disorders, 30 with other chronic diseases, and 30 from the general public and had them review one of two PMI handouts that varied by format, organization, and content. The authors explored preferences for the PMI handout using one-on-one interviews. The authors analyzed the qualitative data to identify relevant themes and patterns using NVivo9 qualitative software. The majority of respondents noted that the formats of the two PMI handouts were more informative than those they currently receive from the pharmacist, with a preference for the 2-column, segmented design. However, respondent PMI preferences varied by age, education, and health status. Patients need simpler and more concise drug information to make better decisions about their health. Current PMI handouts are dense and complex, which can be confusing and not reader friendly. To improve PMI understandability and usefulness, the U.S. Food and Drug Administration is working with stakeholders, consumer advocates, and academics. Findings from this study may help inform future development of more user-friendly PMI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25315585     DOI: 10.1080/10810730.2014.946114

Source DB:  PubMed          Journal:  J Health Commun        ISSN: 1081-0730


  6 in total

Review 1.  Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory Implications.

Authors:  Keith C Ferdinand; Fortunato Fred Senatore; Helene Clayton-Jeter; Dennis R Cryer; John C Lewin; Samar A Nasser; Mona Fiuzat; Robert M Califf
Journal:  J Am Coll Cardiol       Date:  2017-01-31       Impact factor: 24.094

2.  Biennial Analysis of Medication Guide Length and Estimated Readability for New Molecular Entity Drugs, 2011-2017.

Authors:  Paul R Jones; Elisabeth J Walther; Andrew Nguyen; Jonas Santiago; Bryon M Pearsall
Journal:  Ther Innov Regul Sci       Date:  2021-05-10       Impact factor: 1.337

3.  Impact of Age on Patients' Communication and Technology Preferences in the Era of Meaningful Use: Mixed Methods Study.

Authors:  Martina A Clarke; Ann L Fruhling; Marilyn Sitorius; Thomas A Windle; Tamara L Bernard; John R Windle
Journal:  J Med Internet Res       Date:  2020-06-01       Impact factor: 5.428

4.  Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions.

Authors:  Bridget Kelly; Amie O'Donoghue; Sarah Parvanta; Vanessa Boudewyns; Oluwamurewa Oguntimein; Carla Bann; Sue West; Janice Tzeng; Caroline Chandler; Gabriel Madson; Lauren McCormack
Journal:  J Pharm Policy Pract       Date:  2022-03-01

5.  Readability Analysis of the Package Leaflets for Biological Medicines Available on the Internet Between 2007 and 2013: An Analytical Longitudinal Study.

Authors:  María Ángeles Piñero-López; Pilar Modamio; Cecilia F Lastra; Eduardo L Mariño
Journal:  J Med Internet Res       Date:  2016-05-25       Impact factor: 5.428

6.  Conceptualization, Development and Psychometric Evaluations of a New Medication-Related Health Literacy Instrument: The Chinese Medication Literacy Measurement.

Authors:  Hsiang-Wen Lin; Elizabeth H Chang; Yu Ko; Chun-Yu Wang; Yu-Shan Wang; Okti Ratna Mafruhah; Shang-Hua Wu; Yu-Chieh Chen; Yen-Ming Huang
Journal:  Int J Environ Res Public Health       Date:  2020-09-23       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.